BML-259

SynDRA canonical compound SYN0086562 — structure-anchored drug synonym record

Primary target(s)	CDK5
Mechanism of action	CDK inhibitor

All known targets

CDK2
CDK5

Mechanisms of action (all sources)

cyclin-dependent kinase inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

CDK2
CLK2
CLK4
CSNK1D
DYRK1A
HIPK4
SRPK1
TDP1

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

CCNE1
DYR1A
KC1D

Cross-references

PubChem CID: 16760027
ChEMBL: CHEMBL426972
ChEBI: 95031
LINCS BRD: BRD-K71799778

Synonyms

BML 259
N-(5-Isopropylthiazol-2-yl)-2-phenylacetamide
2-phenyl-N-(5-propan-2-yl-2-thiazolyl)acetamide
2-phenyl-N-(5-propan-2-yl-1,3-thiazol-2-yl)acetamide
N-(5-Isopropyl-1,3-thiazol-2-yl)-2-phenylacetamide
2-Phenyl-N-[5-(propan-2-yl)-1,3-thiazol-2-yl]acetamide
N-[5-(1-Methylethyl)-2-thiazolyl]benzeneacetamide
CAY10554
BiomolKI_000077
BiomolKI2_000081
N-(5-Isopropyl-thiazol-2-yl)-2-phenyl-acetamide
orb1303881
SCHEMBL1535301
CHEBI:95031
GLXC-03967
BDBM50155210
CAY-10554
MFCD09802287
AKOS030583154
CCG-100681
SDCCGSBI-0654287.P001
NCGC00163393-01
MS-23670
DB-221389
HY-108348
CS-0028430
G13576
T36964
N-(5-isopropylthiazol-2-yl)-2-phenyl-acetamide
BRD-K71799778-001-02-2

Look up BML-259 in the interactive SynDRA portal →